Navigation Links
Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic Dermatitis For Adults and Children
Date:3/5/2009

SAN FRANCISCO, March 5 /PRNewswire-USNewswire/ -- Atopic dermatitis, the common, chronic, inflammatory skin disease marked by red, itchy rashes, has been increasing in prevalence over the past two decades and affects a disproportionate number of children. According to current estimates, approximately 15 percent to 20 percent of children in the United States and other industrialized countries around the world develop atopic dermatitis in the first few years of life. By comparison, only an estimated 3 percent to 5 percent of adults have an active form of the condition.* Now, a promising new array of therapies targeting different aspects of atopic dermatitis stands to help patients find relief from the physical and emotional pain caused by this complex condition.

Speaking today at the 67th Annual Meeting of the American Academy of Dermatology (Academy), dermatologist Lawrence F. Eichenfield, MD, FAAD, professor of pediatrics and medicine (dermatology) at the University of California, San Diego, School of Medicine, reviewed the latest therapies for atopic dermatitis and how the new understanding of the cause of the condition has led to an improved and more targeted treatment approach.

"There has been an abundance of new research looking at genetic abnormalities associated with atopic dermatitis, including those in the skin's barrier function -- or its protective outer layer," said Dr. Eichenfield. "It appears that a subset of patients with atopic dermatitis and eczema is born with problems with the function of their outer layer of skin, which can cause the skin to be drier and more prone to the absorption of irritants, microbes and allergens that can penetrate the skin and cause adverse reactions. Fortunately, this new understanding is leading to new and better treatments for patients of all ages."

Topical Corticosteroids

Used to diminish the skin's inflammatory response, topic
'/>"/>

SOURCE American Academy of Dermatology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis
2. Revolution Health and EmergingMed Launch Cancer Clinical Trial Matching and Referral Service
3. Malaria Vaccine Developer Sanaria Inc. Receives the Technology Council of Marylands Emerging Company of the Year Award
4. Current and Emerging Drugs Continue to Struggle for Patient Share in the Treatment of Major Depressive Disorder
5. LigoCyte Pharmaceuticals Announces Collaboration With Biogen Idec to Develop Anti-CD103 Therapies
6. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
7. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
8. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
9. Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
10. Vital Therapies Announces Presentation of ELAD(R) Artificial Liver Data at American Association for the Study of Liver Diseases 2007 Annual Meeting
11. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...rstCall/ -- Unilens Vision Inc. (OTC Bulletin Boar...ps, licenses, manufactures, distributes and market...rating results for the first quarter ended Septemb...yalty income, were $1,683,673 in the FY2010 first ... previous year first quarter (FY2009). The decrea...
(Date:11/20/2009)...tCall/ -- Medco Health Solutions, Inc (NYSE: MHS...erican healthcare through an advanced, wired pharm...lity clinical care and fundamentally bending the c...the benefit of patients and payors alike. ,, Th...strategy enable "Smarter Medicine" to help address...
(Date:11/20/2009)... -- Reportlinker.com announces that a new market r..., Pipettes & Pipettors - A Global Market Pers...373/Pipettes--Pipettors---A-Global-Market-Perspect...mp;utm_campaign=prnewswire ,, Pipettes and pi...earch laboratory. Large-scale applications in life...
Breaking Medicine Technology:Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 2Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 4Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12National Press Club Newsmaker Press Conference With Argonne Director Postponed 47709 1Meredith Mathews M D Named Chief Medical Officer for Blue Shield of California 47704 1Meredith Mathews M D Named Chief Medical Officer for Blue Shield of California 47704 2Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences 4524 1Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences 4524 2Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences 4524 3
...hwork Diagnostics, a,genomics-based diagnostics co...work(R) Tissue of Origin Test is the focus of a st...of Molecular Diagnostics. Pathwork,s,genomics-base...gin so that,tissue-specific management can begin. ...erico A. Monzon, M.D., and colleagues from the Uni...
...rotein Assays Validated in CLIA Laboratory, SOUTH.... (Nasdaq: MGRM ) today presented the results of ...to identify metastatic breast,cancer patients who ...udy,results were presented this week at the San An...ogram received confirmation from the College,of Pa...
Other Medicine Technology:Study of Pathwork Diagnostics' Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases 2Study of Pathwork Diagnostics' Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases 3HERmark(TM) Assay Results in Metastatic Breast Cancer Presented at the San Antonio Breast Cancer Symposium 2HERmark(TM) Assay Results in Metastatic Breast Cancer Presented at the San Antonio Breast Cancer Symposium 3HERmark(TM) Assay Results in Metastatic Breast Cancer Presented at the San Antonio Breast Cancer Symposium 4HERmark(TM) Assay Results in Metastatic Breast Cancer Presented at the San Antonio Breast Cancer Symposium 5HERmark(TM) Assay Results in Metastatic Breast Cancer Presented at the San Antonio Breast Cancer Symposium 6
(Date:11/21/2009)... Innovative medical apparel compa...nce , San Clemente, Calif...r of breakthrough medical apparel, today announced...isplay at Medica 2009, a leading international tra...f, Germany. Medelita inaugurates its men,s collect...
(Date:11/21/2009)... Eric J. Hall, president and chie...of America (AFA) issued the following statement re...ction as part of the new annual wellness for Medic...and Affordable Care Act" that was introduced ...Y (PRWEB) November 21, 2009 -- Eric J. Hall, presi...
(Date:11/21/2009)... Linwood Group ask whether there ...be measured? , London, UK... that with up to one in three of the adult UK popu... developing alcohol-related liver disease*, it is ...ng to rehabilitation programmes and residential ce...
(Date:11/20/2009)..., PRINCETON, NJ, Nov. 20 /PRNewswire-FirstCall/ ...at a Special Meeting of Shareholders will be held ...eeting is to consider approval of two special reso...e and authorize the sale of all or substantially a...terms provided for in the asset purchase agreement...
(Date:11/20/2009)... , WASHINGTON, Nov. 20 /PRNewswire-USNewswire...ops urged the Senate to make essential changes its...ral law on abortion funding and conscience protect... immigrants and include strong provisions for adeq...enate health care bill an "enormous disappointment...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2
...ermal ablation and radiation therapy, when used to...perable lung cancer, increases chances of surviv... In a retrospective study looking at patients ove...by radiation for treatment of non-small-cell lung ...
...ied due to suspected chikungunya in three district...spital sources said. // While four patients ...huser respectively, they said. Many others were be...d not chikungunya. The blood samples of the a...
...s Ltd today said Nihon Pharmaceutical Industry Ltd...sed Nippon Chemiphar Ltd // , has launched the ant...ine' tablets in the Japanese market. Clarit... million dollars respectively in Japan, for the ab...
...d insurance company has devised a chip that can be...of recording medical histories. This will assist//...nts' medical data. Horizon Blue Cross and B... The chip can be interpreted with the use of ...
... computers all over the world could help to tackle... the installation of a specialized software.// ...isation Européenne pour la Recherche Nucléaire - t...ter is turned on. When the software runs in ...
...(G8) leaders here Sunday set a series of guideline...dopting a document on the issue.// "A vigoro...the leading cause of death worldwide, is essential...nt emergence of highly pathogenic avian influenza ...
Other Medicine News:Health News:Combination Therapy to the Rescue off Lung Cancer Patients 2Health News:Combination Therapy to the Rescue off Lung Cancer Patients 3Health News:Africa Set to Control Malaria Using Specialized Software 2
Laser 3 mirror Contact Lens 906 L
... OM 900 Ophthalmometer uses a classical distance-i...ee requirements of Helmholtz: 1. The size of the m...he Ophthalmometer and the measured object; 2. The ...ance between the Ophthalmometer and the measured o...
...dows-based image capture and management system tha..., fluorescent and ICG Angiography images. It inter...o obtain images from any ophthalmic device with vi...igh quality colour Retinal Images from non-mydriat...
Non Contact Lens 81 D
Medicine Products: